Baculovirus Vectors Elicit Antigen-Specific Immune Responses in Mice
Open Access
- 15 August 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (16), 8663-8672
- https://doi.org/10.1128/jvi.78.16.8663-8672.2004
Abstract
To characterize the induction of antigen-specific immune response mediated by baculovirus, vectors expressing the E2 glycoprotein of hepatitis C virus or the carcinoembryonic antigen (CEA) under the control of the cytomegalovirus immediate-early promoter-enhancer were constructed. Additionally, a baculovirus vector encoding the E2 glycoprotein (Bac-G-E2) and expressing vesicular stomatitis virus glycoprotein (VSV-G) in the viral envelope was generated by inserting the VSV-G coding sequence downstream of the polyhedrin promoter. Mice were subjected to intramuscular, intranasal, or subcutaneous inoculations with Bac-E2 and the cellular immune response was monitored by ELISPOT and intracellular staining. Additionally, humoral response was monitored by titrating anti-E2 antibodies. Induction of a measurable anti-E2 T-cell response was observed only after intramuscular injection and was predominantly CD8 + specific. The immunogenic properties of baculovirus as vaccine vector were not restricted to E2 because a CEA-specific CD4 + T-cell response was observed upon intramuscular injection of Bac-CEA. Interestingly, the Bac-G-E2 vector was shown to be a more efficient immunogen than Bac-E2, in view of the 10-fold difference in the minimal dose required to elicit a measurable T-cell response upon intramuscular injection. Induction of inflammatory cytokines such as gamma interferon, tumor necrosis factor alpha, and interleukin-6 was detected as early as 6 h postinjection of Bac-G-E2. Most importantly, both vectors elicited CD8 + T cells with effector function capable of lysing target cells loaded with a hepatitis C virus-specific epitope. Additionally, enhanced NK cytolytic activity was detected in immunized mice. Thus, these results further demonstrate that baculovirus may be considered a useful vector for gene therapy.Keywords
This publication has 41 references indexed in Scilit:
- In Vitro and In Vivo Gene Delivery by Recombinant BaculovirusesJournal of Virology, 2003
- Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag GeneJournal of Virology, 2003
- Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag GeneJournal of Virology, 2003
- Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus- and adenovirus-mediated intracerebral gene transfer in vivoGene Therapy, 2002
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Baculovirus-mediated periadventitial gene transfer to rabbit carotid arteryGene Therapy, 2000
- Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement systemGene Therapy, 1998
- Efficient Transduction of Mammalian Cells by a Recombinant Baculovirus Having the Vesicular Stomatitis Virus G GlycoproteinHuman Gene Therapy, 1997
- Gene Transfer into Hepatocytes and Human Liver Tissue by Baculovirus VectorsHuman Gene Therapy, 1996
- Baculovirus Expression Vectors: the Requirements for High Level Expression of Proteins, Including GlycoproteinsJournal of General Virology, 1987